Regeneron raises Eylea guidance

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) gained $17.09 to $377.73 on Thursday after it reported earnings and

Read the full 157 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE